@Risk

Global Life Sciences Companies Cite Supply Quality and Compliance as Top Challenges

February 10, 2010 | Comments (2)

In yesterday’s post about the FDA’s new PREDICT program, I included a few startling statistics about pharmaceuticals imports.

Today, new survey results suggest that global life science companies are increasingly concerned about growing global supply chain complexity and its effect on quality and compliance.

The survey, conducted by Sparta Systems, was administered to professionals in the pharmaceutical, biotech, medical device and blood/tissue industries. The data reveals that: (more…)

Tags: Aravo, collaboration with suppliers, compliance, counterfeit drugs, global sourcing, non-compliance, Pharma supply chain, pharmaceutical supply chain, risk management, risk mitigation, risk strategy, Sparta Systems, supplier risk, supply chain strategy, supply risk, vendor risk management

Medical Device Supply Chains Need Improved Risk Management

October 19, 2009 | Comments (2)

A recent survey by Sparta Systems found that nearly half (45%) of industry professional at top medical device organizations feel their current quality systems are insufficient to mitigate compliance, risk and safety issues associated with their complex supply chains.

I suppose that’s no surprise –considering both the recent globalization of manufacturing and supply of medical products and the multiplicity of supply chain threats today. (more…)